FrancophonIA/ELRC3.0 huggingface dataset:
English: The measures taken are considered effective for enveloped viruses such as human immunodeficiency virus (HIV), hepatitis B virus and hepatitis C virus, and for the non-enveloped hepatitis A virus and parvovirus B19.
Slovenian: Ukrepi so učinkoviti proti virusom z ovojnico, kot so virus imunske pomanjkljivosti (HIV), virusa hepatitisa B in C, ter za viruse brez ovojnice - virus hepatitisa A in viruse B19.
English: - Secondary immunodeficiencies (SID) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (PSAF)* or serum IgG level of <4 g/l.
Slovenian: sekundarni imunski pomanjkljivosti (SID - Secondary Immunodeficiency) pri bolnikih s hudimi ali ponavljajočimi se okužbami, pri neučinkovitem protimikrobnem zdravljenju ter pri bolnikih z bodisi dokazanim okvarjenim nastajanjem specifičnih protiteles (PSAF - Proven Specific Antibody Failure)* ali serumskimi ravnimi IgG <4 g/l.
English: Blood tests Tell your doctor about your treatment with Privigen prior to having any blood tests.
Slovenian: Krvne preiskave Predno imate katero koli krvno preiskavo zdravnika obvestite, da prejemate zdravilo Privigen.
English: In the PID extension study, 55 patients were enrolled and treated with Privigen.
Slovenian: V podaljšani PID študiji je bilo vključenih 55 bolnikov, ki so prejemali zdravilo Privigen.
English: Privigen 100 mg/ml solution for infusion
Slovenian: Privigen 100 mg/ml raztopina za infundiranje
English: CSL Behring GmbH, D-35041 Marburg, Germany
Slovenian: CSL Behring GmbH, D-35041 Marburg, Nemčija
English: Therefore, patients receiving measles vaccine should have their antibody status checked.
Slovenian: Zato je treba pri bolnikih, ki se cepijo proti ošpicam, preveriti status protiteles.
English: - Kawasaki disease.
Slovenian: Kawasakijevi bolezni.
English: The INCAT responder rate was 60.7% (95% confidence interval [42.41, 76.4]).
Slovenian: Stopnja odziva po INCAT je bila 60,7 % (95-% interval zaupanja [42,41; 76,4]).
English: If well tolerated (see section 4.4), the rate of administration may gradually be increased to a maximum of 4.8 ml/kg bw/hr.
Slovenian: Če se dobro prenaša (glejte poglavje 4.4), se hitrost dajanja lahko postopoma poveča na največ 4,8 ml/kg tm/uro.
English: Isolated cases of haemolysis-related renal dysfunction/renal failure or disseminated intravascular coagulation and death have occurred.
Slovenian: Pojavili so se posamični primeri ledvične disfunkcije/ledvične odpovedi ali diseminirane intravaskularne koagulacije in smrti, povezani s hemolizo.
English: Affected are vaccinations with live attenuated virus vaccines such as vaccinations against measles, mumps, rubella and varicella.
Slovenian: Vpliva na celjenje s cepivi z živimi oslabljenimi virusi, kot je cepljenje proti ošpicam, mumpsu, rdečkam in noricam.
English: The recommended starting dose is 0.4 to 0.8 g/kg body weight (bw) given once, followed by at least 0.2 g/kg bw every 3 to 4 weeks.
Slovenian: Priporočeni začetni odmerek je enkrat od 0,4 do 0,8 g/kg telesne mase (tm), ki mu sledi vsaj 0,2 g/kg tm vsake 3 do 4 tedne.
English: Aseptic meningitis syndrome has been reported to occur in association with IVIg treatment.
Slovenian: Poročali so o pojavu sindroma aseptičnega meningitisa v povezavi z zdravljenjem z i.v.
English: • Do not store above 25 °C.
Slovenian: • Zdravilo shranjujte pri temperaturi do 25 °C.
English: Distribution of the IgG subclasses (approx. values): IgG1 69 %
Slovenian: Porazdelitev podrazredov IgG (približne vrednosti):
English: Immunomodulation in adults, and children and adolescents (0-18 years) in: - Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count.
Slovenian: Imunomodulacija pri odraslih, otrocih in mladostnikih (0 - 18 let) pri: primarni imunski trombocitopeniji (ITP) pri bolnikih z velikim tveganjem za krvavitve ali pred kirurškimi posegi za povečanje števila trombocitov.
English: Privigen comes as a ready-to-use solution in single-use vials.
Slovenian: Zdravilo Privigen se dobavlja v obliki raztopine, pripravljene za uporabo, v vialah za enkratno uporabo.
English: In subjects with platelet counts < 50×109 / l after the first dose, 30% showed a platelet response of ≥ 50×109 / l after the mandatory second dose.
Slovenian: Med preiskovanci s številom trombocitov < 50×109/l po prvem odmerku jih je 30 % po obveznem drugem odmerku doseglo odziv trombocitov ≥ 50×109/l.
English: While these reports of renal dysfunction and acute renal failure have been associated with the use of many of the licensed IVIg products containing various excipients such as sucrose, glucose and maltose, those containing sucrose as a stabiliser accounted for a disproportionate share of the total number.
Slovenian: Ig, ki vsebujejo različne pomožne snovi kot so saharoza, glukoza in maltoza, so zdravila s saharozo kot stabilizatorjem obsegala nesorazmeren delež skupnega števila.
English: If the product is diluted to lower concentrations (see section 6.6), immediate use after dilution is recommended.
Slovenian: Če se zdravilo redči, se priporoča takojšnja uporaba zdravila, razredčenega na nižje koncentracije (glejte poglavje 6.6).
English: No differences were seen in the pharmacokinetic parameters between adult and paediatric study patients with PID.
Slovenian: Razlik v farmakokinetičnih parametrih med odraslimi in pediatričnimi bolniki s PID v študiji niso opazili.
English: Overall, 91 % of subjects (188 patients) showed improvement in at least one of the criteria above by week 13.
Slovenian: tedna zabeležili izboljšanje vsaj enega od omenjenih meril pri 91 % preiskovancev (188 bolnikov).
English: 0.2 - 0.4 g/kg bw every 3 to 4 weeks
Slovenian: 0,2 - 0,4 g/kg tm vsake 3 do 4 tedne
English: Replacement therapy in adults, and children and adolescents (0-18 years) in: - Primary immunodeficiency syndromes (PID) with impaired antibody production (see section
Slovenian: Nadomestno zdravljenje odraslih, otrok in mladostnikov (0 - 18 let) pri: sindromih primarne imunske pomanjkljivosti (PID - Primary immunodeficiency syndromes) z okvarjenim nastajanjem protiteles (glejte poglavje 4.4).
English: Chronic inflammatory demyelinating polyneuropathy (CIDP)* The recommended starting dose is 2 g/kg bw divided over 2 to 5 consecutive days followed by maintenance doses of 1 g/kg bw over 1 to 2 consecutive days every 3 weeks.
Slovenian: Kronična vnetna demielinizacijska polinevropatija (CIDP)* Priporočeni začetni odmerek je 2 g/kg tm v deljenih odmerkih 2 do 5 zaporednih dni, ki mu sledijo vzdrževalni odmerki 1 g/kg tm 1 do 2 zaporedna dneva vsake 3 tedne.
English: It is strongly recommended that every time Privigen is administered to a patient, the name and batch number of the product are recorded in order to maintain a link between the patient and the batch of the product.
Slovenian: Vsakokrat, ko damo bolniku zdravilo Privigen, moramo zabeležiti ime in serijo zdravila, da tako ohranimo sledljivost med bolnikom in serijo zdravila.
English: Because the solution contains no preservative, Privigen should be infused as soon as possible.
Slovenian: Raztopina ne vsebuje konzervansov, zato je treba zdravilo Privigen infundirati čim prej.
English: Despite this, when medicinal products prepared from human blood or plasma are administered, the possibility of transmitting infective agents cannot be totally excluded.
Slovenian: Kljub temu pri uporabi zdravil, pripravljenih iz človeške krvi ali plazme, ni mogoče popolnoma izključiti prenosa povzročiteljev.
English: The measures taken are considered effective for enveloped viruses such as human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) and for the non-enveloped viruses such as hepatitis A virus (HAV) and parvovirus B19.
Slovenian: (HIV), virus hepatitisa B (HBV) in virus hepatitisa C (HCV), ter za viruse brez ovojnice, kot sta virus hepatitisa A (HAV) in parvovirus B19.
English: Your doctor will calculate the correct dose for you taking into account your weight, the specific circumstances listed under section 2 “Warnings and precautions” and response to treatment.
Slovenian: Vaš zdravnik bo izračunal pravilni odmerek ob upoštevanju vaše telesne mase, posebnih okoliščin,
English: Discontinuation of IVIg treatment has resulted in remission of AMS within several days without sequelae.
Slovenian: Ig je imela za posledico remisijo AMS v nekaj dneh brez posledic.
English: Privigen 100 mg/ml solution for infusion Human normal immunoglobulin (IVIg)
Slovenian: Privigen 100 mg/ml raztopina za infundiranje humani polispecifični imunoglobulin (i.v.
English: What you need to know before you are given Privigen 3.
Slovenian: "Kaj morate vedeti, preden boste prejeli zdravilo Privigen".
English: Emil-von-Behring-Strasse 76 D-35041 Marburg Germany
Slovenian: Emil-von-Behring-Strasse 76 D-35041 Marburg
English: Contents of the pack and other information
Slovenian: Shranjevanje zdravila Privigen Vsebina pakiranja in dodatne informacije
English: Decreased haemoglobin (including decreased red blood cell count, decreased haematocrit), Coombs` (direct) test positive, increased alanine aminotransferase, increased aspartate aminotransferase, increased blood lactate dehydrogenase
Slovenian: Preiskave znižana koncentracija hemoglobina (vključno z zmanjšanjem števila eritrocitov, zmanjšan hematokrit), pozitivni (neposredni) Coombsov test, povečana alanin-aminotransferaza, povečana aspartat-aminotransferaza, zvišanje ravni laktatdehidrogenaze v krvi pogosti
English: These include: careful selection of blood and plasma donors to make sure those at risk of carrying infections are excluded, the testing of each donation and pools of plasma for signs of virus/infections, the inclusion of steps in the processing of the blood or plasma that can inactivate or remove viruses.
Slovenian: • preiskovanje vsake darovane in zbrane plazme za znake virusa/okužb, • vključevanje korakov pri obdelavi krvi ali plazme, ki lahko deaktivirajo ali odstranijo viruse.
English: If dilution prior to infusion is desired, Privigen may be diluted with 5% glucose solution to a final concentration of 50 mg/ml (5%).
Slovenian: Če želite pred infundiranjem zdravilo razredčiti, lahko zdravilo Privigen razredčite s 5-odstotno raztopino glukoze, da dosežete končno koncentracijo 50 mg/ml (5 %).
English: Because the solution contains no preservative, Privigen should be infused immediately.
Slovenian: Raztopina ne vsebuje konzervansov, zato je treba zdravilo Privigen infundirati takoj.
English: 1.6 - 2 g/kg bw or in divided doses over 2 to 5 days in association with acetylsalicylic acid
Slovenian: 1,6 - 2 g/kg tm ali 2 g/kg tm v razdeljenih odmerkih v obdobju 2 do 5 dni, skupaj z acetilsalicilno kislino v enem odmerku, skupaj z acetilsalicilno kislino
English: The solution should be clear or slightly opalescent and colourless or pale yellow.
Slovenian: Raztopina mora biti bistra ali rahlo opalescentna ter brezbarvna ali rumenkasta.
English: There is clinical evidence of an association between IVIg administration and thromboembolic events such as myocardial infarction, cerebral vascular accident (including stroke), pulmonary embolism and deep vein thromboses which is assumed to be related to a relative increase in blood viscosity through the high influx of immunoglobulin in at-risk patients.
Slovenian: Ig in trombemboličnimi dogodki, kot so miokardni infarkt, cerebrovaskularni dogodek (vključno z možgansko kapjo), pljučna embolija in globoka venska tromboza, za katero se zdi, da je povezana z relativnim povečanjem viskoznosti krvi zaradi velikega dotoka imunoglobulina pri bolnikih s tveganjem.
English: For obtaining an immunoglobulin solution of 50 mg/ml (5%), Privigen 100 mg/ml (10%) should be diluted with an equal volume of the glucose solution.
Slovenian: Za imunoglobulinsko raztopino 50 mg/ml (5 %) morate zdravilo Privigen 100 mg/ml (10 %) razredčiti z enako količino raztopine glukoze.
English: No differences were seen in the pharmacodynamic properties between adult and paediatric study patients.
Slovenian: Pediatrična populacija Razlik v farmakodinamičnih lastnostih med odraslimi in pediatričnimi bolniki v študiji niso opazili.
English: - Guillain-Barré syndrome.
Slovenian: Guillain-Barréjevem sindromu.
English: If dilution is desired, 5% glucose solution should be used.
Slovenian: Če želite zdravilo razredčiti, uporabite 5-odstotno raztopino glukoze.
English: For obtaining an immunoglobulin solution of 50 mg/ml (5%), Privigen 100 mg/ml (10%) should be diluted with an equal volume of the 5% glucose solution.
Slovenian: Za imunoglobulinsko raztopino 50 mg/ml (5 %) morate zdravilo Privigen 100 mg/ml (10 %) razredčiti z enako količino 5-odstotne raztopine glukoze.
English: Chronic inflammatory demyelinating polyneuropathy (CIDP)*
Slovenian: Kronična vnetna demielinizacijska polinevropatija (CIDP)*
English: Headache (including sinus headache, migraine, head discomfort, tension headache)
Slovenian: Bolezni živčevja glavobol (vključno z sinusnim glavobolom, migreno, neprijetnim občutkom v glavi, tenzijski glavobol)
English: Adverse reactions such as chills, headache, dizziness, fever, vomiting, allergic reactions, nausea, arthralgia, low blood pressure and moderate low back pain may occur occasionally in connection with intravenous administration of human immunoglobulin including Privigen.
Slovenian: Občasno se lahko pojavijo neželeni učinki, kot so mrzlica, glavobol, omotica, povečana telesna temperatura, bruhanje, alergijske reakcije, navzea, bolečine v sklepih, nizek krvni tlak in zmerna bolečina v križu v povezavi z intravenskim dajanjem humanih imunoglobulinov, vključno z zdravilom
English: If well tolerated, the rate of administration may gradually be increased to a maximum of 4.8 ml/kg bw/hr.
Slovenian: Če se dobro prenaša, se hitrost dajanja lahko postopoma poveča na največ 4,8 ml/kg tm/uro.
English: CSL Behring GmbH Emil-von-Behring-Strasse 76 D-35041 Marburg Germany
Slovenian: CSL Behring GmbH Emil-von-Behring-Strasse 76 D-35041 Marburg
English: • The active substance is human normal immunoglobulin (antibodies of the type IgG).
Slovenian: ● Učinkovina je humani polispecifični imunoglobulin (protitelesa vrste IgG).
English: starting dose: 0.4 - 0.8 g/kg bw maintenance dose: 0.2 - 0.8 g/kg bw every 3 to 4 weeks to obtain IgG trough levels of at least 5 - 6 g/l
Slovenian: 0,4 - 0,8 g/kg tm vzdrževalni odmerek: 0,2 - 0,8 g/kg tm vsake 3 do 4 tedne, da se doseže najnižja raven IgG vsaj 5-6 g/l
English: Haemolysis has rarely been reported in patients given replacement therapy for PID.
Slovenian: Pri bolnikih, ki so dobivali nadomestno zdravljenje za PID, so redko poročali o hemolizi.
English: Your doctor will decide whether you can receive Privigen during your pregnancy or while you are breast-feeding.
Slovenian: Zdravnik se bo odločil, ali lahko prejemate zdravilo Privigen med nosečnostjo ali dojenjem.
English: Myalgia (including muscle spasms, musculoskeletal stiffness, musculoskeletal pain)
Slovenian: Bolezni mišično skeletnega sistema in vezivnega tkiva mialgija (vključno z mišičnimi krči, mišično skeletno otrdelostjo, mišično-skeletno bolečino)
English: Will be placed in the upper right corner of the label to give total content and volume of the container
Slovenian: Oznaka za skupen volumen in volumen vsebnika bo v zgornjem desnem kotu embalaže.
English: Will be placed in the upper right corner of the main face of the box to give total content and volume of the container
Slovenian: Oznaka za skupno vsebnost in volumen vsebnika bo v zgornjem desnem kotu prednje strani škatle.
English: Privigen is essentially sodium free.
Slovenian: Zdravilo Privigen je v bistvu brez natrija.
English: Dose should be adjusted as necessary to achieve optimal protection against infections, an increase may be necessary in patients with persisting infection; a dose decrease can be considered when the patient remains infection free.
Slovenian: Pri bolnikih s trdovratnimi okužbami bo morda potrebno odmerek povečati; če se okužbe pri bolniku ne ponavljajo več, pa lahko razmislimo o zmanjšanju odmerka.
English: Temporary non-infectious meningitis (reversible aseptic meningitis), irregularity of red blood cell shape (microscopic finding), presence of high platelet counts in the blood (thrombocytosis), sleepiness, shiver (tremor), palpitations, tachycardia, thromboembolic events, lack of blood supply to the lower extremities causing e.g. pain when walking (peripheral vascular disorder), presence of an excess of serum proteins in the urine (proteinuria including increased blood creatinine), injection site pain
Slovenian: Občasni (pojavijo se lahko pri največ 1 od 100 bolnikov): Prehoden neinfekcijski meningitis (reverzibilen aseptični meningitis), nepravilna oblika rdečih krvnih celic (mikroskopski izvid), visoka koncentracija trombocitov v krvi (trombocitoza), zaspanost, drgetanje (tremor), palpitacije, tahikardija, trombembolični dogodki, nezadosten pretok krvi v spodnjih okončinah, ki povzroči npr. bolečino pri hoji (bolezen perifernih žil), prekomerna količina serumskih beljakovin v urinu (proteinurija vključno s povečanim kreatininom v krvi), bolečina na mestu injiciranja.
English: Do not store above 25 °C.
Slovenian: Zdravilo shranjujte pri temperaturi do 25 °C.
English: Sodium content Privigen is essentially sodium-free.
Slovenian: Vsebnost natrija Zdravilo Privigen je v bistvu brez natrija.
English: IVIg products have been shown to cross the placenta, increasingly during the third trimester.
Slovenian: Ig prehajajo skozi posteljico, še najbolj v tretjem trimesečju.
English: Temporary lowering of red blood cell count (anaemia), breakdown of red blood cells (haemolysis), decreased number of white blood cells (leukopenia), hypersensitivity, dizziness (including vertigo), high blood pressure (hypertension), flushing (including hot flush, hyperaemia), hypotension (including decreased blood pressure), breathlessness (dyspnoea including chest pain, chest discomfort, painful breathing), vomiting, loose stools (diarrhea), stomach pain, skin disorder (including rash, itching (pruritus), hives (urticaria), maculopapular rash, redness of the skin (erythema), peeling of the skin (skin exfoliation)), pain in the muscles (including muscle cramps and rigidity), tiredness (fatigue), physical weakness (asthenia), weakness in the muscles, .
Slovenian: visok krvni tlak (hipertenzija), zardevanje (vključno z valovi vročine, hiperemija), hipotenzija (nizek krvni tlak), težko dihanje (dispneja, vključno z bolečinami v prsnem košu, nelagodjem v prsnem košu, bolečim dihanjem), bruhanje, mehko blato (driska), bolečine v trebuhu, kožne motnje (vključno z izpuščajem), srbenje (pruritus), koprivnica (urtikarija), makulo-papulozen izpuščaj, pordelost kože (eritem), lupljenje kože (eksfoliacija kože), bolečine v mišicah (vključno z mišičnimi krči in togostjo),
English: Cases of reversible aseptic meningitis and rare cases of transient cutaneous reactions (including cutaneous lupus erythematosus - frequency unknown) have been observed with human normal immunoglobulin including Privigen.
Slovenian: Pri humanem polispecifičnem imunoglobulinu, vključno z zdravilom Privigen, so opazili primere reverzibilnega aseptičnega meningitisa in redke primere prehodnih kožnih reakcij (vključno s kožnim eritematoznim lupusom - neznana pogostnost).
English: What Privigen is used for
Slovenian: Za kaj se uporablja zdravilo Privigen
English: In a second prospective, multicenter randomized, placebo-controlled clinical study (Polyneuropathy and Treatment with Hizentra, PATH trial), 207 subjects with CIDP were treated with Privigen in the prerandomization phase of the study.
Slovenian: (preskušanje PATH - "Polinevropatija in zdravljenje z zdravilom Hizentra") so v predrandomizacijski fazi študije 207 preiskovancev s CIDP zdravili z zdravilom Privigen.
English: Infections and infestations
Slovenian: Povzročitelji nalezljivih bolezni
English: The solution is clear or slightly opalescent and colourless to pale yellow.
Slovenian: Raztopina je bistra do rahlo opalescentna, brezbarvna do bledo rumena.
English: Fatigue, asthenia (including muscular weakness) Common Injection site pain
Slovenian: zelo pogosti utrujenost, astenija (vključno z mišično šibkostjo) pogosti bolečina na mestu injiciranja občasni
English: In an extension of this study, 13 PID patients (aged 3-65 years) participated in a PK substudy.
Slovenian: V razširitvi te študije je bila pri trinajstih bolnikih s PID (starih od 3-65
English: (e.g. you may feel light-headed, dizzy, faint on standing, cold in the hands and feet, sense an abnormal heart beat or chest pain, or have blurred vision) even when you have shown no hypersensitivity on previous infusions, Tell your doctor or healthcare professional immediately if you notice such signs during the infusion of Privigen.
Slovenian: (npr. občutek prazne glave, omotičnosti, omedlevice v stoječem položaju, občutek mraza v rokah in nogah, občutek nenavadnega srčnega utripa ali bolečine v prsih ali zamegljen vid), celo kadar preobčutljivosti ni bilo pri predhodnih infundiranjih;
English: - Chronic inflammatory demyelinating polyneuropathy (CIDP).
Slovenian: Kronični vnetni demielinizacijski polinevropatiji (CIDP - Chronic inflammatory demyelinating polyneuropathy).
English: Patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
Slovenian: bolniki s kronično vnetno demielinizirajočo polinevropatijo (CIDP - chronic inflammatory demyelinating polyneuropathy).
English: • 0.4 g/kg bw given daily for 2 to 5 days.
Slovenian: • 0,4 g/kg/tm vsak dan 2 do 5 dni.
English: Patients with multifocal motor neuropathy (MMN).
Slovenian: bolniki z multifokalno motorično nevropatijo (MMN).
English: Aseptic technique must be strictly observed during the dilution of Privigen.
Slovenian: Med redčenjem zdravila Privigen je treba dosledno uporabljati aseptično tehniko.
English: Multifocal Motor Neuropathy (MMN)
Slovenian: Multifokalna motorična nevropatija (MMN)
English: 200 or 400 ml of solution in a single vial (type II glass), with a stopper (elastomeric), a cap (aluminium crimp), a flip off disc (plastic), label with integrated hanger.
Slovenian: 200 ali 400 ml raztopine v eni viali (steklo vrste II) z zamaškom (elastomernim), zaporko (z aluminijastim navojem), s tesnilom Flip Off (plastičnim), oznako z vgrajeno zanko.
English: • formation of blood clots which may be carried off in the blood circulation (thromboembolic reactions) and which may result e.g. in myocardial infarction (e.g. when you have sudden chest pain or shortness of breath), stroke (e.g. when you have a sudden onset of muscle weakness, have loss of sensation and/or balance, decreased alertness or difficulty in speaking), blood clots in the arteries of the lungs (e.g. when you have chest pain, difficulty in breathing or are coughing up blood), deep vein thrombosis (e.g. when you have redness, feel warmth, pain, tenderness, or have a swelling of one or both legs),
Slovenian: ● tvorbi krvnih strdkov, ki lahko potujejo po krvnem obtoku (trombembolične reakcije) in lahko npr. povzročijo miokardni infarkt (npr. če občutite nenadno bolečino v prsih ali kratko sapo), možgansko kap (npr. če doživite nenadno mišično oslabelost, izgubo občutenja in/ali ravnotežja,
English: Rarely, haemolytic anaemia requiring transfusion may develop after high dose IVIg treatment including Privigen (see section 4.4).
Slovenian: imunoglobulina, vključno z zdravilom Privigen, razvije hemolitična anemija, zaradi katere je potrebna transfuzija (glejte poglavje 4.4).
English: Therefore, your vaccinating doctor should check the effectiveness of the measles vaccination.
Slovenian: preveriti učinkovitost cepiva proti ošpicam.
English: Primary immune thrombocytopenia (ITP)
Slovenian: Imunomodulacija Primarna imunska trombocitopenija (ITP)
English: In patients defined as INCAT non-responders, muscle strength improved by 5.5 points (95% confidence interval [0.6, 10.2]) as compared to INCAT responders (7.4 points (95% confidence interval [4.0, 11.7])
Slovenian: interval zaupanja [0,6; 10,2]) v primerjavi z bolniki, odzivnimi po INCAT (7,4 točke (95-% interval zaupanja [4,0; 11,7]).